Anticoagulants (blood thinners) on every 2026 Puerto Rico Part D plan
Pick a drug class, or type the drugs you want to check, and see which of the 3 stand-alone Part D plans in Puerto Rico cover each one, on what tier, and with what restrictions.
- Covered
- Covered, needs prior authorization (PA) or step therapy (ST)
- Not on the formulary
- QL 60/30d = quantity limit, 60 units per 30 days
| Drug | HealthSpring Extra Rx$50.00/moS5617-385 | HealthSpring Assurance Rx$65.70/moS5617-348 | AARP Medicare Rx Preferred from UHC$145.10/moS5820-037 |
|---|---|---|---|
| Eliquisapixaban | Tier 317% | Tier 322% | Tier 325%QL 60/30d |
| Xareltorivaroxaban | Tier 317% | Tier 322% | Tier 325%QL 30/30d |
| rivaroxabangeneric Xarelto | Tier 317% | Tier 322% | Tier 325%QL 360/30d |
| dabigatrangeneric Pradaxa | Not covered | Not covered | Tier 425%QL 60/30d |
| Savaysaedoxaban | No 2026 Part D formulary lists this drug in the CMS files: it is too new, no longer sold, or excluded from Part D (as weight-loss-only drugs are). | ||
| warfaringeneric Coumadin | Tier 1$0.00 | Tier 1$0.00 | Tier 125% |
| Jantovenwarfarin | Tier 1$0.00 | Tier 1$0.00 | Tier 125% |
Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.